Alternative strategies for adult pneumococcal polysaccharide vaccination: A cost-effectiveness analysis

This publication has 30 references indexed in Scilit:

• Preventability of Invasive Pneumococcal Disease and Assessment of Current Polysaccharide Vaccine Recommendations for Adults: United States, 2001–2003
  Clinical Infectious Diseases, 2006
• Decreasing invasive pneumococcal disease in the elderly: A state-level analysis
  Vaccine, 2006
• Cost-Effectiveness of Pneumococcal Conjugate Vaccine
  The Pediatric Infectious Disease Journal, 2006
• Changing Epidemiology of Invasive Pneumococcal Disease Among Older Adults in the Era of Pediatric Pneumococcal Conjugate Vaccine
  Published by American Medical Association (AMA) ,2005
• Reactions after 3 or More Doses of Pneumococcal Polysaccharide Vaccine in Adults in Alaska
  Clinical Infectious Diseases, 2005
• Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales
  Vaccine, 2004
• A Need To Update and Revise the Pneumococcal Vaccine Recommendations for Adults
  Annals of Internal Medicine, 2003
• Published by American Medical Association (AMA) ,1999
• Antibody to Capsular Polysaccharides of Streptococcus pneumoniae after Vaccination of Human Immunodeficiency Virus-Infected Subjects with 23-Valent Pneumococcal Vaccine
  The Journal of Infectious Diseases, 1992
• Pneumococcal Antibody Levels One Decade After Immunization of Healthy Adults**Mufson MA, Krause HE, Schiffman G, Hughey D: Decline in pneumococcal antibody levels one decade after administration of polysaccharide vaccine. Clin Res 34:222A, 1986.
  The Lancet Healthy Longevity, 1987